A Propensity Score-Adjusted Comparison of Lenalidomide plus R-CHOP Versus R-CHOP for MYC-Rearranged DLBCL Patients

被引：0
|
作者：
de Jonge, A. Vera [1 ]
van Werkhoven, Erik D. [2 ]
Dinmohamed, Avinash G. [3 ]
Nijland, Marcel [4 ,5 ]
Zwinderman, Aeilko H. [6 ]
Bossuyt, Patrick M. [7 ]
Veldhuis, Martine S. [8 ]
Rutten, Emma G. G. M. [9 ]
Mous, Rogier [10 ]
Vermaat, Joost S. P. [11 ]
Sandberg, Yorick [12 ]
de Jongh, Eva [13 ]
Bilgin, Yavuz M. [14 ]
Boersma, Rinske [15 ]
Koene, Harry R. [16 ]
Kersten, Marie Jose [17 ]
de Jong, Daphne [18 ]
Chamuleau, Martine E. D. [1 ]
机构：
[1] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands
[2] Erasmus MC, Hovon Data Ctr, Dept Hematol, Canc Inst, Rotterdam, Netherlands
[3] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[4] Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands
[5] Univ Groningen, Groningen, Netherlands
[6] Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands
[7] Locat Univ Amsterdam, Dept Clin Epidemiol, Amsterdam UMC, Biostat, Amsterdam, Netherlands
[8] Locat Vrije Univ Amsterdam, Dept Hematol, Amsterdam UMC, Amsterdam, Netherlands
[9] Locat Vrije Univ Amsterdam, Dept Pathol, Amsterdam UMC, Amsterdam, Netherlands
[10] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands
[11] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands
[12] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands
[13] Albert Schweitzer Hosp, Dept Hematol, Dordrecht, Netherlands
[14] Admiraal de Ruijter Hosp, Dept Internal Med, Goes, Netherlands
[15] Amphia Hosp, Dept Internal Med, Breda, Netherlands
[16] St Antonius Hosp, Dept Hematol, Nieuwegein, Netherlands
[17] Acad Med Ctr, Dept Hematol, Amsterdam, Netherlands
[18] Vrije Univ Amsterdam, Amsterdam UMC, Dept Pathol, Canc Ctr Amsterdam, Amsterdam, Netherlands
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2059 / 2060
页数：2
相关论文
共 50 条
  • [21] Retrospective Study of Standard R-CHOP Therapy in Localized DLBCL
    Tomita, Naoto
    Takasaki, Hirotaka
    Miyashita, Kazuho
    Fujisawa, Shin
    Ogusa, Eriko
    Matsuura, Shro
    Kishimoto, Kumiko
    Numata, Ayumi
    Fujita, Atsuko
    Ohshima, Rika
    Kuwabara, Hideyuki
    Hagihara, Maki
    Hashimoto, Chizuko
    Takemura, Sachiya
    Koharazawa, Hideyuki
    Yamazaki, Etsuko
    Fujimaki, Katsumichi
    Taguchi, Jun
    Sakai, Rika
    Ishigatsubo, Yoshiaki
    BLOOD, 2012, 120 (21)
  • [22] MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL.
    Johnson, Nathalie A.
    Ben-Neriah, Susanna
    Savage, Kerry J.
    Lee, Tang
    Horsman, Douglas E.
    Connors, Joseph M.
    Chan, Wing C.
    Lenz, Georg
    Wright, George
    Rimsza, Lisa M.
    Braziel, Rita M.
    Cook, James R.
    Tubbs, Raymond R.
    Weisenburger, Dennis D.
    Campo, Elias
    Rosenwald, Andreas
    Ott, German
    Delabie, Jan
    Jaffe, Elaine S.
    Staudt, Louis M.
    Gascoyne, Randy D.
    BLOOD, 2009, 114 (22) : 452 - 452
  • [23] Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
    Wilson, Wyndham H.
    Wright, George W.
    Huang, Da Wei
    Hodkinson, Brendan
    Balasubramanian, Sriram
    Fan, Yue
    Vermeulen, Jessica
    Shreeve, Martin
    Staudt, Louis M.
    CANCER CELL, 2021, 39 (12) : 1643 - +
  • [24] Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP
    Bantilan, Kurt S.
    Smith, Alexandra N.
    Maurer, Matthew J.
    Teruya-Feldstein, Julie
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Straus, David J.
    Noy, Ariela
    Palomba, M. Lia
    Horwitz, Steven M.
    Hamlin, Paul A.
    Portlock, Carol S.
    Cerhan, James R.
    Habermann, Thomas M.
    Salles, Gilles A.
    Nowakowski, Grzegorz S.
    Moskowitz, Craig H.
    Zelenetz, Andrew D.
    BLOOD ADVANCES, 2024, 8 (09) : 2172 - 2181
  • [25] Split-Dose R-CHOP for Older Patients with Treatment Naive DLBCL
    Kidwell, Adam
    Furqan, Fateeha
    Aschenbrenner, Emilie
    Longo, Walter
    Devata, Sumana
    Hamadani, Mehdi
    Fenske, Timothy S.
    Shah, Nirav N.
    BLOOD, 2024, 144 : 2374 - 2375
  • [26] 80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL
    Takahashi, Anna
    Mishima, Yuko
    Inoue, Norihito
    Kusano, Yoshiharu
    Gunji, Tadahiro
    Ueda, Kyoko
    Nishimura, Noriko
    Nitta, Hideaki
    Yokoyama, Masahiro
    Tsuyama, Naoko
    Takeuchi, Kengo
    Terui, Yasuhito
    Hatake, Kiyohiko
    BLOOD, 2015, 126 (23)
  • [27] Prognostic Differences Based on Ethnicity in Patients with DLBCL Treated with R-CHOP Therapy
    Reid, Jack
    Lee, Winston
    Soma, Lori
    Perry, Anamarija
    Bedell, Victoria
    Hsueh, Julia
    Wu, Xiwei
    Wang, Jinhui
    Weisenburger, Dennis
    Song, Joo
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1470 - S1471
  • [28] Lenalidomide in Combination With R-CHOP (R2-CHOP) in Patients With High Burden Follicular Lymphoma: Phase 2 Study
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (02) : 12 - 15
  • [29] Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL
    Marshall, Shoko
    Nishimura, Noriko
    Inoue, Norihito
    Yamauchi, Hirofumi
    Tsuyama, Naoko
    Takeuchi, Kengo
    Mishima, Yuko
    Yokoyama, Masahiro
    Ogasawara, Toshie
    Mori, Naoki
    Ogawa, Tetsuya
    Sakura, Hiroshi
    Terui, Yasuhito
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (03): : 162 - 169
  • [30] DLBCL 1L-What to Expect beyond R-CHOP?
    Stegemann, Maike
    Denker, Sophy
    Schmitt, Clemens A.
    CANCERS, 2022, 14 (06)
12345